DePrince Race & Zollo Inc (DRZ)’s Phibro Animal Health PAHC Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-51,149	Closed	-$686K	–	216
2022 Q4	$686K	Sell	51,149 -261,964	-84%	-$3.51M	0.02%	196
2022 Q3	$4.16M	Sell	313,113 -145,249	-32%	-$2.51M	0.11%	161
2022 Q2	$8.77M	Sell	458,362 -21,009	-4%	-$398K	0.2%	129
2022 Q1	$9.56M	Buy	479,371 +91,835	+24%	+$1.85M	0.19%	140
2021 Q4	$7.91M	Buy	387,536 +115,663	+43%	+$2.47M	0.2%	137
2021 Q3	$5.86M	Buy	271,873 +6,376	+2%	+$153K	0.16%	158
2021 Q2	$7.67M	Sell	265,497 -8,758	-3%	-$237K	0.19%	153
2021 Q1	$6.69M	Buy	274,255 +90,059	+49%	+$2.03M	0.18%	159
2020 Q4	$3.58M	Buy	+184,196	New	+$3.39M	0.11%	176

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s PAHC Position: Q1 2023 in Review

DePrince Race & Zollo Inc (DRZ) sold out of Phibro Animal Health (PAHC) in Q1 2023, closing a stake of 51,149 shares — an estimated $686K sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in PAHC in Q4 2020 and held it in 9 quarters. The position peaked at $9.56M in Q1 2022. 133 funds tracked by Wall St. Rank hold PAHC as of Q1 2023.

DePrince Race & Zollo Inc (DRZ) reported no remaining Phibro Animal Health position as of Q1 2023 after selling out during the quarter.
DePrince Race & Zollo Inc (DRZ) sold 51,149 Phibro Animal Health shares in Q1 2023, an estimated $686K.
DePrince Race & Zollo Inc (DRZ) first reported a position in Phibro Animal Health in Q4 2020 and held it in 9 quarters.
DePrince Race & Zollo Inc (DRZ)'s Phibro Animal Health position peaked at $9.56M in Q1 2022.
133 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2023.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q1 2023, filed 15 May 2023.